目次

Table of Contents

List of Tables

List of Figures
Introduction
Global Markets Direct Report Coverage
Hyperalgesia - Overview
Hyperalgesia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Hyperalgesia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hyperalgesia - Companies Involved in Therapeutics Development
Caventure Drug Discovery Inc
Charleston Laboratories Inc
Exodos Life Sciences Limited Partnership
Novartis AG
Hyperalgesia - Drug Profiles
AX-007 - Drug Profile
Product Description
Mechanism Of Action
BAM-822 - Drug Profile
Product Description
Mechanism Of Action
CAV-1001 - Drug Profile
Product Description
Mechanism Of Action
Drug for Hyperalgesia - Drug Profile
Product Description
Mechanism Of Action
ketoprofen - Drug Profile
Product Description
Mechanism Of Action
mol-002291 - Drug Profile
Product Description
Mechanism Of Action
Monoclonal Antibody to Inhibit TGF-Beta-1 for Chronic Pancreatitis Pain and Hyperalgesia - Drug Profile
Product Description
Mechanism Of Action
Small Molecules to Antagonize GPR4 for Arthritis, Hyperalgesia and Oncology - Drug Profile
Product Description
Mechanism Of Action
ZH-853 - Drug Profile
Product Description
Mechanism Of Action
Hyperalgesia - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Hyperalgesia, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Hyperalgesia - Pipeline by Caventure Drug Discovery Inc, 2022
Hyperalgesia - Pipeline by Charleston Laboratories Inc, 2022
Hyperalgesia - Pipeline by Exodos Life Sciences Limited Partnership, 2022
Hyperalgesia - Pipeline by Novartis AG, 2022
Hyperalgesia - Dormant Projects, 2022

List of Figures
Number of Products under Development for Hyperalgesia, 2022
Number of Products under Development by Companies, 2022
Number of Products by Targets, 2022
Number of Products by Stage and Targets, 2022
Number of Products by Mechanism of Actions, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Routes of Administration, 2022